These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30300039)

  • 1. Quantitative dynamic contrast-enhanced ultrasound may help predict the outcome of hepatocellular carcinoma after microwave ablation.
    Zhan Y; Zhou F; Yu X; Luo F; Liu F; Liang P; Cheng Z; Han Z; Yu J
    Int J Hyperthermia; 2019 Jan; 35(1):105-111. PubMed ID: 30300039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
    Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
    Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral perfusion may affect microwave ablation area of hepatocellular carcinoma.
    Zhou F; Sun Y; Hou Y; Liu F; Yu X
    Int J Hyperthermia; 2023; 40(1):2268892. PubMed ID: 37927295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application.
    An C; Li X; Zhang M; Yang J; Cheng Z; Yu X; Han Z; Liu F; Dong L; Yu J; Liang P
    BMC Cancer; 2020 Jan; 20(1):44. PubMed ID: 31959147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of enhancement rate by enhanced ultrasound in hepatitis B virus-positive hepatocellular carcinoma undergoing radiofrequency ablation.
    Zhou G; Cai ZQ; Luo J; Hu ZX; Luo H; Wu H; Chen Q
    Asia Pac J Clin Oncol; 2019 Aug; 15(4):238-243. PubMed ID: 31119840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
    Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
    World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Chen BB; Hsu CY; Yu CW; Liang PC; Hsu C; Hsu CH; Cheng AL; Shih TT
    Radiology; 2016 Nov; 281(2):454-464. PubMed ID: 27171020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies.
    Rennert J; Wiesinger I; Beyer LP; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):73-83. PubMed ID: 31561352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
    Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
    Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradable starch microspheres transarterial chemoembolisation (DSM-TACE) of HCC: Dynamic Contrast-Enhanced Ultrasonography (DCE-US) based evaluation of therapeutic efficacy using a novel perfusion software.
    Wiggermann P; Heibl M; Niessen C; Müller-Wille R; Gössmann H; Uller W; Poschenrieder F; Schreyer AG; Wohlgemuth WA; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2012; 52(2-4):123-9. PubMed ID: 22960293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
    Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
    Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma originating in the caudate lobe: A pilot clinical study.
    Peng Y; Cui D; Li W; Ding M; Shi Y; Wang T; Shi D; Chi J; Li P; Zhai B
    J Cancer Res Ther; 2021 Jul; 17(3):764-770. PubMed ID: 34269311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and histological grading.
    Pei XQ; Liu LZ; Liu M; Zheng W; Han F; Li AH; Cai MY
    Br J Radiol; 2012 Sep; 85(1017):e740-7. PubMed ID: 22096225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L; Li HL; Guo CY; Luo SX
    Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-guided percutaneous microwave ablation vs. surgical resection for thoracoabdominal wall implants from hepatocellular carcinoma: intermediate-term results.
    An C; Hu ZL; Liang P; Cheng ZG; Han ZY; Yu J; Liu FY
    Int J Hyperthermia; 2018 Nov; 34(7):1067-1076. PubMed ID: 29161924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: oncologic outcomes and advanced assistive technology.
    An C; Cheng Z; Yu X; Han Z; Liu F; Li X; Wu SS; Yu J; Liang P
    Int J Hyperthermia; 2020; 37(1):89-100. PubMed ID: 31969036
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors.
    Ma S; Ding M; Li J; Wang T; Qi X; Shi Y; Ming Y; Chi J; Wang Z; Tang X; Cui D; Zhang Y; Zhai B
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):131-142. PubMed ID: 27650934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between the time-intensity parameters of contrast-enhanced ultrasound and clinical prognosis of hepatocellular carcinoma.
    Yang YL; Yang RJ; Liu X; Liu J; Chao LJ; Duan YY
    Clin Imaging; 2013; 37(2):308-12. PubMed ID: 23465984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A).
    Lee H; Yoon CJ; Seong NJ; Jeong SH; Kim JW
    Korean J Radiol; 2018; 19(6):1130-1139. PubMed ID: 30386144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.